Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
The rise of GLP-1 obesity treatment has transformed how clinicians approach patients with both obesity and diabetes
The body naturally produces this hormone, which is essential in regulating When To Consider Telehealth Medical Weight Loss Telehealth medical weight loss offers a more structured and effective approach to weight management
you can also search for UK trials via NIHR Be Part of Research (www.bepartofresearch.nihr.ac.uk) Do not discontinue any existing prescribed medication (such as semaglutide or tirzepatide) in anticipation of retatrutide becoming available For clinicians: Familiarise yourself with the LY3437943 development code and ongoing Phase 3 trial data, as patients may present with questions informed by media coverage Be prepared to discuss the distinction between investigational and approved therapies , and the importance of evidence-based prescribing Monitor MHRA and NICE communications for updates on regulatory submissions and technology appraisals From a safety perspective, the adverse effect profile observed in Phase 2 trials (as reported in the 2023 New England Journal of Medicine publication) was broadly consistent with other GLP-1-based therapies, with nausea, vomiting, diarrhoea, and decreased appetite being the most commonly reported side effects
Weekly weight loss injections : Once-weekly medication shipped directly to your home after your consultation
Over time, cheeks can flatten, and skin may begin to sag
